Timber Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
ROME ZACHARY director
 Value Appreciation Rights 79,326 $0.01 $793
Option
ROME ZACHARY director
 Common Stock, par value $0.001 per share 79,326 $0.01 $793
Purchase
KOCONIS JOHN director, officer: CEO & Presid..
 Common Stock, par value $0.001 per share 20,000 $0.38 $7,680
Purchase
MENDELSOHN ALAN officer: Chief Medical Officer
 Common Stock, par value $0.001 per share 10,000 $0.47 $4,700
Purchase
SITAR EDWARD J director
 Common Stock, par value $0.001 per share 15,000 $0.46 $6,900
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 225,000 $0.94 $211,050
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 150,500 $0.92 $138,912
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 150,000 $0.91 $136,800
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 100,000 $0.93 $92,700
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 100,000 $0.92 $91,800
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 100,000 $0.92 $91,800
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 100,000 $0.92 $91,800
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 50,000 $0.91 $45,400
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 50,000 $0.91 $45,400
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 75,000 $1 $75,075
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 28,450 $1.26 $35,932
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 146,465 $1.27 $185,571
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 185,229 $1.26 $233,944
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 96,481 $1.27 $122,917
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 305,540 $1.29 $393,536
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 9,879 $1.26 $12,448
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 8,670 $1.26 $10,950
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 47,736 $1.27 $60,625
Purchase
MENDELSOHN ALAN
Common Stock, par value $0.001 per share 1,988 $2.17 $4,314
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 100,694 $1.03 $103,715
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 87,060 $1.03 $89,585
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 455 $1.03 $469
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 7,483 $1.03 $7,707
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.001 per share 32,943 $1.04 $34,392
Sale
TARDIMED SCIENCES LLC 10 percent owner
 Common Stock, par value $0.01 per share 55,008 $0.01 $550
Sale
TIMBER PHARMACEUTICALS LLC other: Former 10% Owner
 Common Stock, par value $0.01 per share 55,008 $0.01 $550
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
 Common Stock 327,870 $1.02 $334,427
Sale
KRAMMER ANJA B director
 Common stock 115,874 N/A N/A
Sale
MORLOCK STEPHEN director
 Common stock 220,766 $0.18 $39,738
Sale
MORLOCK STEPHEN director
 Common stock 214,091 $0.18 $38,536
Sale
MORLOCK STEPHEN director
 Common stock 439,099 $0.19 $83,429
Sale
KRAMMER ANJA B director
 Common stock 297,500 $0.19 $56,525
Sale
KRAMMER ANJA B director
 Common stock 100,000 $0.19 $19,000
Sale
KRAMMER ANJA B director
 Common stock 102,500 $0.19 $19,475
Purchase
TIERNEY DAVID S officer: Pres and CEO
 Common Stock 100,000 N/A N/A
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
 Common Stock 2,000,000 $0.36 $720,000
Purchase
MORLOCK STEPHEN director
 Common stock 330,000 N/A N/A
Purchase
MORLOCK STEPHEN director
 Warrant to purchase common stock 330,000 N/A N/A
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
 Common Stock 296,394 $0.2 $59,279
Purchase
FRANKLIN RESOURCES INC 10 percent owner
 Common Stock 250,000 N/A N/A
Purchase
VIVO CAPITAL FUND VIII, L.P. 10 percent owner
 Common Stock 1,282,052 $0.78 $1,000,001
Purchase
VIVO CAPITAL FUND VIII, L.P. 10 percent owner
 Common Stock Warrant (right to buy) 641,026 $0.9 $576,923
Purchase
MORLOCK STEPHEN director
 Warrants to purchase common stock 321,428 N/A N/A
Purchase
MORLOCK STEPHEN director
 Common stock 428,571 N/A N/A
Purchase
FRANKLIN RESOURCES INC 10 percent owner
 Class A Warrants 4,375,000 N/A N/A

Showing 1 to 50 of 62 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: